ArticleInvestigational new drugs2017

Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924).

Kit Man Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.